NEDD9 overexpression correlates with poor prognosis in gastric cancer

Tumor Biology

Volumn 35, Issue 7, 2014, Pages 6351-6356

  Liu, Yi ^a   Wang, Ding ^a   Zhao, Kui Ling ^a   Zhu, Jian Wei ^a   Yin, Hai Bing ^a   Wei, Ying Ze ^a   Wu, Zhi Jun ^a   Cheng, Guo Jian ^a   Wang, Feng ^a   Ni, Feng ^a   Wang, Xiao Lin ^a   Cao, Guang Xin ^a   Huang, Jian ^a   Cai, Jing ^a  

^a NANTONG UNIVERSITY   (China)

Author keywords

Gastric cancer; Immunohistochemistry; NEDD9; Prognosis

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; FLUOROURACIL; NEURAL PRECURSOR CELL EXPRESSED DEVELOPMENTALLY DOWNREGULATED 9; PEPTIDES AND PROTEINS; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CANCER ADJUVANT THERAPY; CANCER PROGNOSIS; CANCER STAGING; CANCER TISSUE; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MULTIPLE CYCLE TREATMENT; OVERALL SURVIVAL; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN OVEREXPRESSION; STOMACH CANCER; TUMOR DIFFERENTIATION; TUMOR INVASION;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; AGED; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; KAPLAN-MEIER ESTIMATE; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM STAGING; PHOSPHOPROTEINS; PROGNOSIS; STOMACH NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 84905051764     PISSN: 10104283     EISSN: 14230380     Source Type: Journal    
DOI: 10.1007/s13277-014-1839-7     Document Type: Article

References (17)

1. Jemal A, Bray F, Center MM, et al. Global cancer statistics. CA Cancer J Clin. 2011;61:69-90.
2. Ferlay J, Shin HR, Bray F, et al. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 2010;127:2893-917.
3. Yang L. Incidence and mortality of gastric cancer in China. World J Gastroenterol. 2006;12:17-20. (Pubitemid 43126077)
4. Macdonald JS, Smalley SR, Benedetti J, et al. Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction. N Engl J Med. 2001;345:725-30.
5. Law SF, Estojak J, Wang B, et al. Human enhancer of filamentation 1, a novel p130cas-like docking protein, associates with focal adhesion kinase and induces pseudohyphal growth in Saccharomyces cerevisiae. Mol Cell Biol. 1996;16(7):3327-37.
6. Minegishi M, Tachibana K, Sato T, et al. Structure and function of Cas-L, a 105-kD Crk-associated substrate-related protein that is involved in beta 1 integrin-mediated signaling in lymphocytes. J Exp Med. 1996;184(4):1365-75. (Pubitemid 26354693)
7. Kumar S, Tomooka Y, Noda M. Identification of a set of genes with developmentally down-regulated expression in the mouse brain. Biochem Biophys Res Commun. 1992;185:1155-61.
8. Tikhmyanova N, Golemis EA. NEDD9 and BCAR1 negatively regulate E-cadherin membrane localization, and promote E-cadherin degradation. PLoS One. 2011;6:e22102.
9. Kim M, Gans JD, Nogueira C, et al. Comparative oncogenomics identifies NEDD9 as a melanoma metastasis gene. Cell. 2006;125(7):1269-81. (Pubitemid 43949521)
10. Natarajan M, Stewart JE, Golemis EA, et al. HEF1 is a necessary and specific downstream effector of FAK that promotes the migration of glioblastoma cells. Oncogene. 2006;25(12):1721-32.
11. Guo W, Ren D, Chen X, et al. HEF1 promotes epithelial mesenchymal transition and bone invasion in prostate cancer under the regulation of microRNA-145. J Cell Biochem. 2013;114(7):1606-15.
12. Xue YZ, Sheng YY, Liu ZL, et al. Expression of NEDD9 in pancreatic ductal adenocarcinoma and its clinical significance. Tumour Biol. 2013;34(2):895-9.
13. Li Y, Bavarva JH, Wang Z, et al. HEF1, a novel target of Wnt signaling, promotes colonic cell migration and cancer progression. Oncogene. 2011;30:2633-43.
14. Xia D, Holla VR, Wang D, et al. HEF1 is a crucial mediator of the proliferative effects of prostaglandin E(2) on colon cancer cells. Cancer Res. 2010;70(2):824-31.
15. Kim SH, Xia D, Kim SW, et al. Human enhancer of filamentation 1 Is a mediator of hypoxia-inducible factor-1alpha-mediated migration in colorectal carcinoma cells. Cancer Res. 2010;70(10):4054-63.
16. Izumchenko E, Singh MK, Plotnikova OV, et al. NEDD9 promotes oncogenic signaling in mammary tumor development. Cancer Res. 2009;69:7198-206.
17. Sima N, Cheng X, Ye F, et al. The overexpression of scaffolding protein NEDD9 promotes migration and invasion in cervical cancer via tyrosine phosphorylated FAK and SRC. PLoS One. 2013;8(9):e74594.